CIDRAP newsletters options
In a trial, the oral drug Paxlovid reduced the risk of hospitalization or death by 89%.
One study shows 85% protection against hospitalization.
A detailed national survey of Americans, which included residents of the four largest US metropolitan areas, found that about half of those unwilling to be vaccinated against COVID-19 were unlikely to change their minds. A research team based at Emerson University published their findings yesterday in Scientific Reports.
Most pregnant women with a reported history of penicillin allergy who were tested were found not to be allergic and could tolerate penicillin during labor, according to a small retrospective study presented today at the annual scientific meeting of the American College of Allergy, Asthma and Immunology (ACAAI).
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The monetary benefit could be as high as $17 billion if vaccines are affordably priced, the report suggests.
More than 28 million extra years of life were lost among 31 well-off nations.
The plan will affect all employers with 100 or more employees, or 84 million Americans.
Officials warn that the continent could see another half million COVID-19 deaths by February.
The initial COVID-19 vaccine campaign in the United States was associated with fewer infections, emergency department (ED) visits, and hospitalizations among adults 65 and older, finds a study yesterday in The Lancet.
A new report from the Centers for Disease Control and Prevention (CDC) shows that progress against healthcare-associated infections (HAIs), including those caused by antibiotic-resistant bacteria, took a step back in 2020.
The high protection was found even amid high Alpha and Delta variant circulation.
Covaxin, made by Bharat Biotech, is an inactivated vaccine given in two doses 4 weeks apart.
COVID-19 didn't appear to spread efficiently within and among teams last fall.
"Please know we have conducted a thorough review of the safety data."
Spanish, Italian, and UK physicians reported high levels of depression and anxiety during the first two waves of the COVID-19 pandemic, finds a study yesterday in PLOS One.
Also, new CDC data show why immune-compromised people need an added COVID vaccine dose.
A hybrid of natural and vaccine immunity may protect better against breakthrough infections.
The ACIP recommendation now goes to CDC head Walensky for final approval.
Two doses of the Pfizer/BioNTech and Moderna mRNA COVID-19 vaccines were 93% and 96% effective, respectively, in preventing severe, critical, or fatal disease caused by the highly transmissible Delta (B1617.2) variant, a study today in Nature Medicine finds.
